Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy

Código QR

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy

Abstract Objectives Our study aimed to determine the prevalence and prognosis of acute coronary syndrome with non-obstructive coronary artery (ACS-NOCA) in patients with hypertrophic cardiomyopathy (HCM). Methods and results We enrolled a total of 200 consecutive patients with HCM over a 139-month p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sarinya Puwanant, Angkawipa Trongtorsak, Chaisiri Wanlapakorn, Nattakorn Songsirisuk, Aekarach Ariyachaipanich, Smonporn Boonyaratavej
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/dbe4d21018f8493d82ee62ade22df081
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Maike Schuldt, et al.
Publicado: (2021)

Clinical predictors of the presence of obstructive sleep apnea in patients with hypertrophic cardiomyopathy
por: Haobo Xu, et al.
Publicado: (2021)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Martino Deidda, et al.
Publicado: (2021)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Li-Min Liu, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021)

Relationship Between Obstructive Sleep Apnea and Late Gadolinium Enhancement and Their Effect on Cardiac Arrhythmias in Patients with Hypertrophic Obstructive Cardiomyopathy
por: Wang S, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Qiang Liu, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy in South Western Nigeria
por: Amam Mbakwem, et al.
Publicado: (2017)

Feline hypertrophic cardiomyopathy: an echocardiographic approach
por: Silva,AC, et al.
Publicado: (2013)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021)

The Role of Mental Stress in Ischaemia with No Obstructive Coronary Artery Disease and Coronary Vasomotor Disorders
por: Roos ET van der Meer, et al.
Publicado: (2021)

Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy
por: Cheddadi L, et al.
Publicado: (2017)

Clinical Characteristics, Sex Differences, and Outcomes in Patients With Normal or Near‐Normal Coronary Arteries, Non‐Obstructive or Obstructive Coronary Artery Disease
por: Michelle L. Ouellette, et al.
Publicado: (2018)

Sex differences in the prognosis of patients with hypertrophic cardiomyopathy
por: Minkwan Kim, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: a modern view of the problem
por: Amina M. Alieva, et al.
Publicado: (2020)

Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement
por: Milind Y. Desai, et al.
Publicado: (2021)

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy
por: Umut Karabulut, et al.
Publicado: (2021)

Diagnostic Approach to Patients with Stable Angina and No Obstructive Coronary Arteries
por: Gaetano Antonio Lanza
Publicado: (2019)

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
por: Styliani Vakrou, et al.
Publicado: (2021)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Elena V. Filatova, et al.
Publicado: (2021)

Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China
por: Shuo-yan An, et al.
Publicado: (2017)

Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project
por: Łukasz Kuźma, et al.
Publicado: (2021)

Distance between valvular leaflet and coronary ostium predicting risk of coronary obstruction during TAVR
por: Jun-Hyok Oh, et al.
Publicado: (2021)

What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries
por: Robert Sykes, et al.
Publicado: (2021)

Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Rory Gallen, MB, BcH, BAO, et al.
Publicado: (2021)

Utility of the oxygen pulse in the diagnosis of obstructive coronary artery disease in physically fit patients
por: Bradley J. Petek, et al.
Publicado: (2021)

Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.
por: Hajime Nakaoka, et al.
Publicado: (2013)

Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy
por: Dimitrios Ntelios, et al.
Publicado: (2021)

Prevalence of Third Coronary Artery: Variation or Constant Coronary Artery?
por: Maric,Dusica L, et al.
Publicado: (2018)

Identification of key proteins and lncRNAs in hypertrophic cardiomyopathy by integrated network analysis
por: Xiaofeng Hu, et al.
Publicado: (2019)

Left ventricular non-compaction with hypertrophic cardiomyopathy, a mutually beneficial combination?
por: Vijayaraghavan Govindan, et al.
Publicado: (2021)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Pratch Sukumolanan, et al.
Publicado: (2021)

Age, creatinine clearance, and ejection fraction (mACEF) score predicts long-term cardiac mortality in patients with hypertrophic obstructive cardiomyopathy treated non-invasively
por: Jun Gao, et al.
Publicado: (2021)

Incremental value of QT interval for the prediction of obstructive coronary artery disease in patients with chest pain
por: Dong-Hyuk Cho, et al.
Publicado: (2021)

OUTCOME OF PERCUTANEOUS CORONARY INTERVENTION IN TOTALLY OCCLUDED CORONARY ARTERIES
por: Nisar Ahmed, et al.
Publicado: (2019)

Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy
por: Jiwon Seo, et al.
Publicado: (2020)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction
por: Xiaojia Zhang, et al.
Publicado: (2018)

MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment
por: Ying X Gue, et al.
Publicado: (2020)

Case Report: Area of Focus of Myocardial Infarction With Non-obstructive Coronary Arteries in Eosinophilic Granulomatosis With Polyangiitis
por: Xiaoxian Cui, et al.
Publicado: (2021)